Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan
· Delayed Price · Currency is TWD 177.50
+4.50 (2.60%)
Apr 2, 2025, 1:30 PM CST
Lumosa Therapeutics Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -424.78 | -238.04 | -494.66 | 95.95 | -322.56 | Upgrade
|
| Depreciation & Amortization | 8.3 | 23.1 | 21.92 | 32.02 | 35.63 | Upgrade
|
| Other Amortization | 0.12 | 0.26 | 0.25 | 0.08 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 10.37 | - | 102.52 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 102.24 | -119.08 | 217.4 | -627.61 | -24.5 | Upgrade
|
| Stock-Based Compensation | 37.96 | 8.59 | 5.03 | 3.22 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.18 | 0.15 | - | - | - | Upgrade
|
| Other Operating Activities | -18.45 | -19.75 | -9.18 | 0.1 | -12.9 | Upgrade
|
| Change in Accounts Receivable | -8.81 | 1.84 | -4.31 | 7.93 | 261.66 | Upgrade
|
| Change in Inventory | 6.13 | 4.77 | -26.3 | -50.61 | -7.78 | Upgrade
|
| Change in Accounts Payable | -0.07 | 0.5 | -13.51 | 14.47 | -7.81 | Upgrade
|
| Change in Unearned Revenue | - | -3.85 | 2.2 | -0.32 | 0.32 | Upgrade
|
| Change in Other Net Operating Assets | 0.86 | 2.91 | 0.7 | -30.35 | -51.17 | Upgrade
|
| Operating Cash Flow | -296.33 | -328.21 | -300.46 | -452.6 | -129.11 | Upgrade
|
| Capital Expenditures | -0.45 | -14.32 | -2.29 | -0.09 | -0.68 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.7 | - | -0.49 | - | Upgrade
|
| Investment in Securities | -790.65 | 247.6 | -66.92 | -36.41 | 7.04 | Upgrade
|
| Other Investing Activities | 4 | 8 | - | - | - | Upgrade
|
| Investing Cash Flow | -787.1 | 240.58 | -69.2 | -36.98 | 6.36 | Upgrade
|
| Long-Term Debt Repaid | -4.13 | -4.33 | -4.65 | -5.47 | -6.8 | Upgrade
|
| Net Debt Issued (Repaid) | -4.13 | -4.33 | -4.65 | -5.47 | -6.8 | Upgrade
|
| Issuance of Common Stock | 897.75 | 0.29 | 0.81 | 436.74 | 859.38 | Upgrade
|
| Other Financing Activities | - | 0.1 | 50 | - | - | Upgrade
|
| Financing Cash Flow | 893.62 | -3.95 | 46.17 | 431.28 | 852.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | -0.03 | 0.02 | -0.01 | 0 | Upgrade
|
| Net Cash Flow | -189.76 | -91.6 | -323.47 | -58.32 | 729.83 | Upgrade
|
| Free Cash Flow | -296.78 | -342.53 | -302.74 | -452.69 | -129.79 | Upgrade
|
| Free Cash Flow Margin | -757.97% | -601.82% | -1136.33% | -2607.34% | -599.47% | Upgrade
|
| Free Cash Flow Per Share | -1.81 | -2.11 | -1.86 | -3.00 | -1.07 | Upgrade
|
| Cash Interest Paid | 0.19 | 0.05 | 0.15 | 0.26 | 0.15 | Upgrade
|
| Cash Income Tax Paid | 0.39 | 0.57 | -0.61 | 0.06 | 13.32 | Upgrade
|
| Levered Free Cash Flow | -180.01 | -212.08 | -207.14 | -293.1 | 4.06 | Upgrade
|
| Unlevered Free Cash Flow | -179.9 | -212.05 | -207.05 | -292.94 | 4.15 | Upgrade
|
| Change in Net Working Capital | 2.62 | -5.87 | 40.75 | 58.77 | -182.68 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.